VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 127 filers reported holding VOYAGER THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 0.75 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24,661 | – | 3,182 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 9,391,176 | $155,894,000 | 54.58% |
| Casdin Capital, LLC | 1,135,000 | $18,841,000 | 4.59% |
| DAFNA Capital Management LLC | 157,000 | $2,606,000 | 1.40% |
| Aevitas Wealth Management, Inc. | 84,323 | $1,400,000 | 1.33% |
| BB BIOTECH AG | 1,539,520 | $25,556,000 | 0.72% |
| Eventide Asset Management | 703,425 | $11,677,000 | 0.61% |
| Iguana Healthcare Management, LLC | 50,000 | $830,000 | 0.54% |
| Virtus ETF Advisers LLC | 23,586 | $392,000 | 0.49% |
| Birchview Capital, LP | 43,000 | $714,000 | 0.42% |
| THOMPSON DAVIS & CO., INC. | 7,485 | $124,000 | 0.29% |